Divisional role of quantitative HER2 testing in breast cancer.

about

Divisional role of quantitative HER2 testing in breast cancer.

Item

http://www.wikidata.org/entity/Q46521614

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Divisional role of quantitative HER2 testing in breast cancer.

@en

Divisional role of quantitative HER2 testing in breast cancer.

@nl

type

Item

label

Divisional role of quantitative HER2 testing in breast cancer.

@en

Divisional role of quantitative HER2 testing in breast cancer.

@nl

prefLabel

Divisional role of quantitative HER2 testing in breast cancer.

@en

Divisional role of quantitative HER2 testing in breast cancer.

@nl

P1476

Divisional role of quantitative HER2 testing in breast cancer.

@en

P2093

Hirotaka Iwase

http://www.w3.org/2001/XMLSchema#string

Ken-ichi Iyama

http://www.w3.org/2001/XMLSchema#string

Mutsuko Yamamoto-Ibusuki

http://www.w3.org/2001/XMLSchema#string

Peifen Fu

http://www.w3.org/2001/XMLSchema#string

Saori Fujiwara

http://www.w3.org/2001/XMLSchema#string

Satoko Yamamoto

http://www.w3.org/2001/XMLSchema#string

Yumi Honda

http://www.w3.org/2001/XMLSchema#string

Yutaka Yamamoto

http://www.w3.org/2001/XMLSchema#string

P2860

Real-time PCR complements immunohistochemistry in the determination of HER-2/neu status in breast cancer

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

The influence of immunohistochemistry on mRNA recovery from microdissected frozen and formalin-fixed, paraffin-embedded sections.

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer.

Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches.

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer.

Adjuvant trastuzumab in HER2-positive breast cancer.

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors

P2888

s12282-013-0467-1

P304

161-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12282-013-0467-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236253535

http://www.w3.org/2001/XMLSchema#string

P698

23604955

http://www.w3.org/2001/XMLSchema#string